wrote down all the sources I found

I have 25 hours. Lord oh mighty.

1 files changed, 140 insertions, 0 deletions

diff --git a/markley/20_biblio b/markley/20_biblio
new file mode 100644
index 0000000..84da197
--- /dev/null
+++ b/markley/20_biblio
@@ -0,0 +1,140 @@
+https://en.wikipedia.org/wiki/Insulin_(medication)
+https://en.wikipedia.org/wiki/Insulin_glargine
+
+https://www.sciencehistory.org/historical-profile/frederick-banting-charles-best-james-collip-and-john-macleod
+    A history of insulin, and the ?two? researchers who discovered that
+    pig insulin was able to be substituted in dogs and in people
+
+http://www.madehow.com/Volume-7/Insulin.html
+- (bad source) how insulin is made
+
+https://gh.bmj.com/content/3/5/e000850
+https://pubmed.ncbi.nlm.nih.gov/30271626/
+    - Read the article through the GT paywall (PubMed)
+    - About how much insulin costs to manufacture
+
+phttps://www.citizen.org/article/outrage-of-the-month-pharmas-price-gouging-on-insulin-is-literally-killing-patients/
+    - Has some valuable links, about how much Insulin is costing
+
+https://www.youtube.com/watch?v=SYmvBoXi0Q8
+    - Channel 4 AOC talking about Campaign Finance
+
+http://web.a.ebscohost.com.prx.library.gatech.edu/ehost/pdfviewer/pdfviewer?vid=1&sid=88e625e8-0732-4c85-aa12-a8b8cd5ded42%40sessionmgr4008
+    - Behind the paywall, I think
+    - Insulin.
+    - Some upcoming results about the a
+
+https://www.opensecrets.org/political-action-committees-pacs/C00144345/summary/2020
+    - More money in finance stuff
+    - Sanofi PAC gave nearly a million, with $5K donations from employes
+
+https://www.opensecrets.org/orgs/aetna-inc/totals?id=D000000296#totals-affiliates
+    - Aetna money in finance
+
+https://www.usatoday.com/story/news/politics/2019/08/26/pharma-industry-ups-donations-senate-republicans-mcconnell/2116231001/
+https://www.statnews.com/feature/prescription-politics/prescription-politics/
+    - General pharma industry payoffs from USA Today (meh)
+
+https://search.proquest.com/docview/1829913470?rfr_id=info%3Axri%2Fsid%3Aprimo
+    - Behind the paywall
+    - FDA about DMCA exemption for medical devices
+
+https://doggett.house.gov/media-center/press-releases/doggett-brown-announce-bicameral-medicare-drug-price-negotiation-bill
+    - Lloyd Doggett's website
+    - From the Public Citizen website about Medicare Negotiations
+
+https://go.gale.com/ps/retrieve.do?tabID=T003&resultListType=RESULT_LIST&searchResultsType=SingleTab&hitCount=11184&searchType=BasicSearchForm&currentPosition=12&docId=GALE%7CA640027797&docType=Article&sort=Relevance&contentSegment=ZGPP-MOD1&prodId=ITOF&pageNum=1&contentSet=GALE%7CA640027797&searchId=R2&userGroupName=gainstoftech&inPS=true
+    - I don't understand it, but Patent board rules in Sanofi's favor
+      over a patent on PCSK9 antibodies (?)
+
+https://gatech-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_miscellaneous_1698956637&context=PC&vid=01GALI_GIT&lang=en_US&search_scope=primo_central&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,insulin&offset=0
+    - Generic insulin glargine??
+    - About its efficacy in a double-blind trial
+
+https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2717499
+- Cost-related insulin underuse
+
+https://www.openmarketsinstitute.org/learn/drug-prices-monopoly
+- "Between 1995 and 2015, 60 pharmaceutical companies merged into just
+  10."
+- Def not behind paywall but wow
+- Lotsa good links
+- the nber.org link is from this, I think
+- Haven't finished reading
+
+https://pubmed.ncbi.nlm.nih.gov/24866023/
+- "Insulin glargine was the first once-daily, long-acting insulin analog
+  to be introduced into clinical practice more than 10 years ago and is
+  specifically designed to provide basal insulin requirements."
+- Nice pubmed article (paywall)
+"pancreatectomized dogs"
+
+https://patents.google.com/patent/US8048854B2/en
+- The patent itself
+- Gives a date of 2027-07-05 for expiry
+
+https://www.npr.org/templates/story/story.php?storyId=1869210
+- 4:33 segment
+- "Drug Companies Cope with Declines, May Merge"
+- About the Sanofi-Aventus merger in 2004. The problem with the industry
+  is "a lack of new drugs"
+
+https://healthcostinstitute.org/diabetes-and-insulin/spending-on-individuals-with-type-1-diabetes-and-the-role-of-rapidly-increasing-insulin-prices
+- Some pricing data on per-unit, increases in 2012--2016, other stuff
+
+https://www.sanofi.com/en/about-us/through-time/
+- Sanofi's company history: Hoechst, Synthelabo, and Phone-Poulenc Rorer
+- https://en.wikipedia.org/wiki/Hoechst_AG
+    - It was a holocaust bad
+- Merger of like four companies (wtf) = $126B mkt cap (SNY)
+
+https://www-proquest-com.prx.library.gatech.edu/docview/1664805626?accountid=11107
+- Why is there no generic insulin?
+- Kinda limited explanation
+- Behind the paywall
+
+https://www.proquest.com/docview/223927797/5F156A7B9D3F4195PQ/1?accountid=11107
+- Corporate Payoffs and Pravix from Sanofi
+- 2006
+- Behind the paywall
+
+https://www.ftc.gov/news-events/media-resources/mergers-competition/pay-delay
+- FTC recent paydelay stuff
+
+https://www.drugs.com/nda/mk_1293_160805.html
+- Semi-reliable, probably (not a good enough source, maybe)
+- Press release
+- Lusduna Nexvue, a tentatively approved follow-on for glargine
+https://www.fiercepharma.com/marketing/despite-scoring-fda-nod-merck-s-follow-med-lusduna-must-wait-to-challenge-lantus
+- Doesn't exactly fit the narrative, but these are other big companies
+    - Plus the Hatch whatever act
+    - Nevermind, it does. So these massive companies just got into the
+      mkt to sell at the $300 prices. WTF
+- Sanofi has two competitor insulin glargines
+
+https://projects.propublica.org/represent/lobbying/search?commit=Search&fields%5B%5D=_all&page=2&search=sanofi&utf8=%E2%9C%93
+- The current lobbying projects that Sanofi is doing. I didn't get much
+
+https://www.opensecrets.org/Lobby/clientsum.php?id=D000000215&year=2020
+- Another lobbying site
+- Sanofi put out $4M in lobbying!
+
+https://go.gale.com/ps/i.do?p=GPS&u=gainstoftech&id=GALE|A202627653&v=2.1&it=r
+- 2009: "Sanofi-Aventis in acquisition mode"
+- Uhh I don't think this will be useful, but it's here.
+    - What I really want to know is how many companies has Sanofi/its
+      predecessors acquired.
+
+https://pharmaphorum.com/articles/a_history_of-_sanofi/
+- Might be a wiki citation, so good
+- Includes some merger info, might be incomplete on the Aventis side but
+  prob pretty comprehensive
+
+https://www.nber.org/system/files/working_papers/w7280/w7280.pdf
+- I didn't have time to read it
+- 60 pages on antitrust laws (and court?)
+
+https://go.gale.com/ps/retrieve.do?tabID=Journals&resultListType=RESULT_LIST&searchResultsType=MultiTab&hitCount=6&searchType=BasicSearchForm&currentPosition=2&docId=GALE%7CA101569966&docType=Article&sort=Relevance&contentSegment=ZICC-MOD1&prodId=CSIC&pageNum=1&contentSet=GALE%7CA101569966&searchId=R2&userGroupName=gainstoftech&inPS=true
+- "Physicians and the pharmaceutical industry: a dysfunctional
+  relationship"
+- Skimmed it. Seems useful?